Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ALDX Relative to the S&P 500

ALDX Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Aldeyra Therapeutics, Inc. (NASD:ALDX) seasonal charts above shows that a Buy Date of May 26 and a Sell Date of September 27 has resulted in a geometric average return of 22.78% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 37.32% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

To download ALDX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ALDX